ArticleHealth promotion and chronic disease prevention in Canada : research, policy and practice2018
At-a-glance - Impact of drug overdose-related deaths on life expectancy at birth in British Columbia.
Article in Health promotion and chronic disease prevention in Canada : research, policy and practice, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 31 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed.
- Enhancing identification of suspected unregulated drug toxicity deaths in administrative health records: a case study among people with HIV in British Columbia, Canada.BMC public health · 2026Article
- Development and validation of a fentanyl quantification model for drug checking services.Drug and alcohol dependence reports · 2026Article
- Association between prenatal opioid exposure and health, education, and foster care between ages 0 and 18.PNAS nexus · 2026Article
- Public support of and attitudes toward decriminalization of possession of illegal drugs among the general population in British Columbia.Substance abuse treatment, prevention, and policy · 2025Article
- Article
- Characterizing opioid agonist therapy uptake and factors associated with treatment retention among people with HIV in British Columbia, Canada.Preventive medicine reports · 2023Article
- Opioid agonist therapy and mortality among First Nations and other residents with concurrent alcohol use disorder in British Columbia, Canada: A population-based cohort study.Drug and alcohol dependence · 2023Article
- Moving towards a continuum of safer supply options for people who use drugs: A qualitative study exploring national perspectives on safer supply among professional stakeholders in Canada.Substance abuse treatment, prevention, and policy · 2022Article
- Stepping up to the Canadian opioid crisis: a longitudinal analysis of the correlation between socioeconomic status and population rates of opioid-related mortality, hospitalization and emergency department visits (2000-2017).Health promotion and chronic disease prevention in Canada : research, policy and practice · 2022Article
- Implementation of a nurse-led overdose prevention site in a hospital setting: lessons learned from St. Paul's Hospital, Vancouver, Canada.Harm reduction journal · 2022Article
- A spatiotemporal analysis of inequalities in life expectancy and 20 causes of mortality in sub-neighbourhoods of Metro Vancouver, British Columbia, Canada, 1990-2016.Health & place · 2021Article
- Awareness of fentanyl exposure and the associated overdose risks among people who inject drugs in a Canadian setting.Drug and alcohol review · 2021Article
- Correlations between Changes in Medical Opioid Dispensing and Contributions of Fentanyl to Opioid-Related Overdose Fatalities: Exploratory Analyses from Canada.International journal of environmental research and public health · 2021Article
- Comparing rapid micro-induction and standard induction of buprenorphine/naloxone for treatment of opioid use disorder: protocol for an open-label, parallel-group, superiority, randomized controlled trial.Addiction science & clinical practice · 2021Article
- Opioid use, regulation, and harms in Brazil: a comprehensive narrative overview of available data and indicators.Substance abuse treatment, prevention, and policy · 2021Review
- Overactivity assessment in chronic pain: The development and psychometric evaluation of a multifaceted self-report assessment.European journal of pain (London, England) · 2021Article
- The implementation and role of a staff naloxone program for non-profit community-based sites in British Columbia: A descriptive study.PloS one · 2021Article
- Drug-related deaths in a population-level cohort of people living with and without hepatitis C virus in British Columbia, Canada.The International journal on drug policy · 2020Article
- Applying principles of injury and infectious disease control to the opioid mortality epidemic in North America: critical intervention gaps.Journal of public health (Oxford, England) · 2020Article
- Article
Corrections and comments
- Erratum issued
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We quantified the contributions of leading causes of death and drug overdose to changes in life expectancy at birth over time and inequalities by sex and socioeconomic status in British Columbia. From 2014 to 2016, life expectancy at birth declined by 0.38 years and drug overdose deaths (mainly opioid-involved) contributed a loss of 0.12 years of the decrease. The analysis also demonstrated that the higher drug overdose mortality among males and among those in lower socioeconomic status communities contributed to a differential decrease in life expectancy at birth for males and for those in the latter category.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.